666 related articles for article (PubMed ID: 22744829)
1. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
3. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
[TBL] [Abstract][Full Text] [Related]
4. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
[TBL] [Abstract][Full Text] [Related]
5. Case series of bail-out procedures with a balloon-expandable sheath after unsuccessful introduction of the NovaFlex device.
Fusari M; Bona V; Biglioli P
Innovations (Phila); 2012; 7(1):45-51. PubMed ID: 22576035
[TBL] [Abstract][Full Text] [Related]
6. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
7. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
[TBL] [Abstract][Full Text] [Related]
9. A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation.
Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; van der Linden M; Juthier F; Banfi C; Hurt C; Samim M; Hillaert M; van Herwerden L; Bertrand ME; Doevendans PA; Van Belle E
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):398-405. PubMed ID: 22377664
[TBL] [Abstract][Full Text] [Related]
10. Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis.
Abu Saleh WK; Tang GH; Ahmad H; Cohen M; Undemir C; Lansman SL; Reyes M; Barker CM; Kleiman NS; Reardon MJ; Ramlawi B
Catheter Cardiovasc Interv; 2016 Jul; 88(1):135-43. PubMed ID: 26603266
[TBL] [Abstract][Full Text] [Related]
11. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
[TBL] [Abstract][Full Text] [Related]
12. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT.
Yang TH; Webb JG; Blanke P; Dvir D; Hansson NC; Nørgaard BL; Thompson CR; Thomas M; Wendler O; Vahanian A; Himbert D; Kodali SK; Hahn RT; Thourani VH; Schymik G; Precious B; Berger A; Wood DA; Pibarot P; Rodés-Cabau J; Jaber WA; Leon MB; Walther T; Leipsic J
JACC Cardiovasc Interv; 2015 Mar; 8(3):462-471. PubMed ID: 25790764
[TBL] [Abstract][Full Text] [Related]
13. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept.
Blumenstein JM; Van Linden A; Moellmann H; Seeburger J; Rastan A; Kim WK; Mohr FW; Kempfert J; Walther T
Thorac Cardiovasc Surg; 2013 Aug; 61(5):409-13. PubMed ID: 23247690
[TBL] [Abstract][Full Text] [Related]
14. Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety.
Mylotte D; Sudre A; Teiger E; Obadia JF; Lee M; Spence M; Khamis H; Al Nooryani A; Delhaye C; Amr G; Koussa M; Debry N; Piazza N; Modine T
JACC Cardiovasc Interv; 2016 Mar; 9(5):472-80. PubMed ID: 26965937
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve.
Binder RK; Rodés-Cabau J; Wood DA; Mok M; Leipsic J; De Larochellière R; Toggweiler S; Dumont E; Freeman M; Willson AB; Webb JG
JACC Cardiovasc Interv; 2013 Mar; 6(3):293-300. PubMed ID: 23517842
[TBL] [Abstract][Full Text] [Related]
16. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
Osten MD; Feindel C; Greutmann M; Chamberlain K; Meineri M; Rubin B; Mezody M; Ivanov J; Butany J; Horlick EM
Catheter Cardiovasc Interv; 2010 Mar; 75(4):475-85. PubMed ID: 19937781
[TBL] [Abstract][Full Text] [Related]
18. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation is less enhanced in the new balloon expandable Edwards Sapien 3 valve compared to its predecessor model (Edwards Sapien XT).
Fateh-Moghadam S; Voesch S; Htun P; Jorbenadze R; Geisler T; Gawaz M; Bocksch W
Thromb Haemost; 2016 Jan; 115(1):109-16. PubMed ID: 26311528
[TBL] [Abstract][Full Text] [Related]
20. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
